Stroke can affect females very differently from males, and therefore preclinical research on underlying mechanisms and the effects of interventions should not be restricted to male subjects, and treatment strategies for stroke should be tailored to benefit both sexes. Previously, we demonstrated that a multinutrient intervention (Fortasyn) improved impairments after ischemic stroke induction in male C57Bl/6 mice, but the therapeutic potential of this dietary treatment remained to be investigated in females. We now induced a transient middle cerebral artery occlusion (tMCAo) in C57Bl/6 female mice and immediately after surgery switched to either Fortasyn or an isocaloric Control diet. The stroke females performed several behavioral and motor tasks before and after tMCAo and were scanned in an 11.7 Tesla magnetic resonance imaging (MRI) scanner to assess brain perfusion, integrity, and functional connectivity. To assess brain plasticity, inflammation, and vascular integrity, immunohistochemistry was performed after killing of the mice. We found that the multinutrient intervention had diverse effects on the stroke-induced impairments in females. Similar to previous observations in male stroke mice, brain integrity, sensorimotor integration and neurogenesis benefitted from Fortasyn, but impairments in activity and motor skills were not improved in female stroke mice. Overall, Fortasyn effects in the female stroke mice seem more modest in comparison to previously investigated male stroke mice. We suggest that with further optimization of treatment protocols more information on the efficacy of specific interventions in stroked females can be gathered. This in turn will help with the development of (gender-specific) treatment regimens for cerebrovascular diseases such as stroke.
potentially salvageable tissue (Astrup et al. 1981) . Acute symptoms of ischemic stroke can be facial weakness, hemiparesis, hemianopsia, and speech difficulties (Hankey and Blacker 2015) , depending on the occluded artery. While patients can (partially) recover from some of these symptoms, demonstrating the capacity of the brain for repair and compensation after injury (Zeiler and Krakauer 2013) , up to 40% of stroke patients remain physically disabled (LuengoFernandez et al. 2013) . Ischemic stroke can also result in cognitive and behavioral deficits, as demonstrated by the propensity of stroke patients to develop Alzheimer's disease (AD) (Kalaria 2000) . Rather than being the result of damage at the site of the stroke lesion, these cognitive and behavioral deficits seem to be caused by lesions to brain networks (Siegel et al. 2016) . All of these severe long-term consequences of stroke emphasize the need for effective treatment strategies. Currently, ischemic stroke treatment is mainly aimed at restoring blood flow by thrombolysis (e.g., treatment with tissue plasminogen activator) or thrombectomy and treating motor impairments (Hankey 2017) . However, these treatment strategies only have a small therapeutic window to be effective (Lyden 2008) and do not improve the cognitive and behavioral deficits induced by stroke. Therefore, novel treatment strategies, that address both the stroke lesion and affected brain networks, need to be developed.
The food we consume can greatly affect our health. For example, adhering to a so-called Western diet, consisting of large amounts of saturated fatty acids, increases the risk to develop stroke (Foroughi et al. 2013) and AD (Hooijmans and Kiliaan 2008) . On the other hand, consuming a Mediterranean diet containing, among other things, relatively high amounts of fish, nuts and olive oil is considered beneficial (Scarmeas et al. 2006) . As shown in several large double-blind controlled studies like PREDIMED (Estruch et al. 2013 ) and the Northern Manhattan study (Gardener et al. 2011) , intake of a Mediterranean diet lowers the risk of vascular events such as stroke. Therefore, a diet containing components of the Mediterranean diet such as unsaturated fatty acids, vitamins, and polyphenols may be a valid approach for the prevention and treatment of vascular diseases. A specific multinutrient intervention (Fortasyn) was developed as a therapeutic intervention for early-stage AD (van Wijk et al. 2014 ). It consists of several different dietary components facilitating neuronal membrane formation, including fatty acids, phospholipids, and vitamins. Indeed, this diet has been shown to protect mouse models with AD-like pathology from neuronal degeneration Wiesmann et al. 2016) . Interestingly, vascular health also benefited from Fortasyn, as shown by increases in cerebral blood flow (CBF) after treatment. This finding suggests that this specific combination of dietary components may also improve the impairments associated with cerebrovascular diseases (CVD) such as stroke. Recently, we demonstrated the therapeutic potential of the above mentioned multinutrient intervention on ischemic stroke in male C57Bl/6 mice that received a focal ischemic stroke lesion (Wiesmann et al. 2017) . In these male mice, treatment with Fortasyn improved stroke-induced impairments in functional and structural connectivity, cerebral blood flow and motor function and reduced neuroinflammation. This suggested that this multinutrient intervention may indeed serve as a promising treatment for ischemic stroke patients. However, care has to be taken in generalizing results obtained in males to female subjects, as it is known that responses to treatments can differ between sexes (Soldin and Mattison 2009) .
Because of the genetic and biological differences between males and females, stroke impacts women very differently from males (Haast et al. 2012) . In general, women experience more severe strokes than men. These severe stroke events mostly occur after menopause, suggestive of a protective role of estrogens (Liu et al. 2010) . Even though traditionally stroke is mostly associated with older age, the number of young adults that experience a stroke event is rising (Kissela et al. 2012) . In pre-menopausal women, stroke risk is increased with, for example, pregnancy, a history of migraines and the use of hormonal contraception (Ekker et al. 2016) . Personalized treatment strategies that can address stroke both in elderly and young women are therefore required.
In this study, we aimed to investigate the therapeutic potential of the Fortasyn diet in female stroke mice. We used the same experimental set-up as the previously performed study in male C57Bl/6 mice (Wiesmann et al. 2017) . In short, we induced a focal ischemic stroke in 3-4 month old C57Bl/6 female mice by transiently occluding the middle cerebral artery (tMCAo) for 30 min and subsequently feeding them either the Fortasyn diet or an isocaloric Control diet. Using state-of-the-art imaging techniques and behavioral tasks, we then investigated the therapeutic effect of the multinutrient intervention on brain structure and function, cerebral blood flow, behavior, and motor skills. Gathering more knowledge on the effect of this dietary treatment on stroke in female mice will help with the development of gender-specific treatment regimens for CVD.
Material and methods

Animals
A randomized double-blind controlled study using 24 female C57BL/ 6JRj mice (Harlan Laboratories Inc., Horst, the Netherlands; 2-3 months old) was conducted at the preclinical imaging center of the Radboud university medical center (Radboudumc) (Nijmegen, the Netherlands). Before tMCAo, the animals were group-housed (four animals per cage) in enriched, individually ventilated cages. Standard food pellets (Ssniff rm/h V1534-000, Bio Services, Uden, The Netherlands) and autoclaved water were available ad libitum. In the room where the mice were kept, there was an artificial 12 h light-dark cycle (lights on at 7 a.m.), humidity control, and background music.
Room temperature was kept constant at 21 AE 1°C. After tMCAo, the mice were housed separately to monitor intake of the experimental diets by each individual mouse. Experiments were performed according to Dutch federal regulations for animal protection and the European Union Directive of 22 September 2010 (2010/63/EU). They were approved and pre-registered by the Animal Ethics Committee (called the Dierexperimentencommissie or DEC, RU-DEC 2014-171) of the Radboudumc. Furthermore, our experiments were performed according to the (updated) recommendations made by the Stroke Therapy Academic Industry Roundtable (STAIR) for the preclinical development of therapies for ischemic stroke (Stroke Therapy Academic Industry et al. 1999; Fisher et al. 2009 ) and ARRIVE guidelines (Kilkenny et al. 2010) . All applicable international, national, and institutional guidelines for the care and use of animals were followed. Our study was also in concurrence with the European regulations on ethics and responsible conduct regarding scientific communication. All behavioral and MRI experiments were performed in the Preclinical Imaging Centre of the Radboudumc between 8 a.m. and 6 p.m.
Transient middle cerebral artery occlusion (tMCAo)
At 3-4 months of age, all mice underwent transient (30 min) occlusion of the right middle cerebral artery (tMCAo), thus mimicking one of the most common types of ischemic stroke in patients (Endres and Dirnagl 2002; Engel et al. 2011) . The intraluminal occlusion model was performed as described elsewhere with minor modifications (Engel et al. 2011; Zinnhardt et al. 2015) . To ensure comparability to our previous study (Wiesmann et al. 2017) , the exact procedures were followed and all surgeries were performed by the same experienced researcher who performed the surgeries on the male mice (co-author D.R.). In short, mice were anesthetized with 1.5% isoflurane (Abbott Animal Health, Abbott Park, IL, USA) in a 2 : 1 air and oxygen mixture and were kept under anesthesia during the total time of the surgery. Next, a 7-0 monofilament (tip diameter 190-200 lm, coating length 2-3 mm, 70SPRePK5, Doccol Corp., Sharon, MA, USA) was inserted in the right common carotid artery and positioned at the point where the middle cerebral artery branches out. A Laser Doppler probe (moorVMS-LDF2, Moor Instruments, UK) placed on the skull of the mice monitored CBF to assess the efficacy of the occlusion (≥ 80% loss of CBF). The middle cerebral artery was occluded for 30 min before retracting the filament allowing for reperfusion. After surgery, mice were carefully monitored to assess pain or other discomforts. Mice were weighed at least once a week. Exclusion criteria were decreased motor activity (< 50% of the baseline measurements combined from the baseline values of each behavioral test) or extreme weight loss (> 20% within three consecutive days). Lesion size was comparable in all animals and no dietary effect on lesion size could be detected as measured with a T2-weighted Rapid Acquisition with Relaxation Enhancement (RARE) sequence (data not shown). None of the mice died during or after tMCAo or reached the aforementioned exclusion criteria.
Group allocation and diets
Immediately after tMCAo, using a random sequence generator mice were randomly divided into two experimental groups, with one group being fed the Fortasyn diet (n = 12) and the other group receiving an isocaloric Control diet (n = 12). Group sizes were calculated based on the effect sizes (Type I error: 0.05, statistical power: 0.80), exclusion and mortality rates determined in our previous study (Wiesmann et al. 2017) .
Both the Fortasyn and the Control diet were based on AIN-93M (Reeves et al. 1993 ) with 5% fat, but differed with respect to their fatty acid composition and some additional nutrients. The Fortasyn diet contained 0.1% coconut oil, 1.9% corn oil, and 3.0% fish oil, while the Control diet contained 1.9% soy oil, 0.9% coconut oil, and 2.2% corn oil. Furthermore, the Fortasyn diet contained a specific multinutrient composition comprising uridine, omega-3 polyunsaturated fatty acids (PUFAs), choline, B vitamins, phospholipids, and antioxidants (the specific composition is specified in (Wiesmann et al. 2017) . Both diets were manufactured and pelleted by Ssniff (Soest, Germany) and stored at À20°C until use. In this study, the same batches of the diets as given to the mice in our previous study (Wiesmann et al. 2017) were used. Food intake was measured two times a week to calculate the average daily food intake per mouse.
Behavior, cognition, and motor tasks All imaging and behavioral procedures and all data analyses were performed by researchers who were blinded to the treatment conditions. One mouse of the Fortasyn group was excluded from all of the experiments described below because of an enlarged kidney, leaving n = 12 in the Control group and n = 11 in the Fortasyn group. During the behavioral training/acclimatization before the tMCAo, all mice were trained on, and acclimatized to the testing equipment of both the grip strength test and the pole test. Resembling the actual experimental post-stroke situation all mice performed before the tMCAo only five consecutive trials for the grip strength test (5 for Fig. 1 Study design. Before ischemic stroke induction (tMCAo on day 0), female C57Bl/6 mice were allowed to acclimatize after which they underwent several pre-stroke behavioral tests (baseline measurements). Immediately after stroke induction, the females were given either the Fortasyn multinutrient diet (n = 11) or an isocaloric Control diet (n = 12). After the stroke, several behavioral tasks were (again) performed. Furthermore, MRI scanning was performed twice after stroke induction. Ppi, prepulse inhibition; tMCAo, transient middle cerebral artery occlusion; ORT, novel object recognition test. trapeze/forepaws + 5 for grid/all four paws) and also five consecutive trials for the pole test. The design of this study is illustrated in Fig. 1 .
Open field Locomotion and explorative behavior were evaluated for 10 min in a square open field (45 9 45 9 30 cm) prior to the tMCAo and diet switch (pre-stroke) and 3 and 21 days post-stroke as previously described. Using EthoVision XT10.1 (Noldus, Wageningen, The Netherlands), locomotion was automatically recorded. The floor of the arena was divided into center, periphery, and corners. The frequency of entering these zones was measured automatically. In addition, exploratory behavior was manually scored (walking, sitting, wall leaning, rearing, and grooming) and analyzed as previously described (Streijger et al. 2005) . One mouse of the Fortasyn group was considered an outlier in the baseline measurements (i.e., hyperactive mouse) and was therefore excluded from the open field analyses.
Grip strength test
The grip strength test was performed prior to the tMCAo and diet switch (pre-stroke) and 14 and 27 days post-stroke using a grip strength meter (Grip Strength Meter, 47200, Ugo Basile, Italy) as previously described (Wiesmann et al. 2017) . Muscle strength in the forelimbs (trapeze) and in all four limbs (grid) was determined. Trials where the mouse grasped the trapeze with one forelimb or grasped the grid with less than four limbs were excluded from the analyses. One mouse of the Fortasyn group was excluded from the analyses, as pre-stroke it did not demonstrate a trapeze pull with both forelimbs. For both the trapeze and the grid, the maximum value of the peak force (in gf) was averaged per experimental group.
Pole test
The pole test was performed prior to the tMCAo and diet switch (prestroke) and 15 days post-stroke as previously described (Wiesmann et al. 2017) . The time needed to turn completely downward was measured manually, while the time to reach the floor was determined with EthoVision XT10.1 (Noldus) and used to determine downward velocity (cm/s). The first trial of each pole test was excluded from the statistical analyses (acclimatization). Furthermore, trials where a mouse was turning on the pole before being released by the researcher were excluded and each mouse had to have at least three successful trials. Based on these criteria, three mice of the Control group and one mouse of the Fortasyn group were excluded from the pole test analyses. Furthermore, the turning time of four additional mice (two of the Control group and two of the Fortasyn group) could not be determined (e.g., the mouse walked over the top of the pole). These four mice were included in the downward velocity analyses.
Prepulse inhibition (PPI)
To examine sensorimotor integration, prepulse inhibition (PPI) was examined 16 days after stroke induction as previously described (Janssen et al. 2015) . The startle reactivity of the mice was measured in the SR-LAB startle response system (San Diego Instruments, San Diego, CA, USA). PPI of the mouse was calculated during the second block of startle pulses (PPI (%) = 100 9 (response to startle pulse -response to startle pulse after a prepulse)/response to startle pulse). Furthermore, habituation to 120 dB startle pulses (given without prepulses) was examined by comparing the responses to startle pulses (in arbitrary units) of block 1 to block 3 (Streijger et al. 2005) . Two mice of the Control group were considered statistical outliers (i.e., high response) in the no stimulus and 120 dB startle pulse trials, respectively, and were therefore excluded from the PPI analyses.
Novel object recognition test (ORT)
All mice performed the ORT to measure short-term memory, 22 days (first acquisition day; 30 min delay) and 23 (second acquisition day; 60 min delay) days post-stroke as previously described (supplemental (Wiesmann et al. 2017) . Using EthoVision XT10.1 (Noldus, Wageningen, The Netherlands), a recognition index (i.e., the time spent examining the novel object (N) minus the time spent examining the familiar object (F) in the test trial) was determined to assess recognition memory. Mice were excluded from the analyses when they either demonstrated a preference for one of the objects in the familiarization trials (> 75% of time spend on one object) or did not explore either N or F in the test trial. One mouse of the Fortasyn group was considered an outlier in the baseline measurements (i.e., hyperactive mouse) and was therefore excluded from the ORT analyses.
MRI protocol MRI measurements were performed at 7 and 35 days post-stroke on a 11.7 T BioSpec Avance III small animal MR system (Bruker BioSpin, Ettlingen, Germany) operating on Paravision 6.0.1 software platform (Bruker, Karlsruhe, Germany) as previously described Wiesmann et al. 2017) . In short, mice were anesthetized with isoflurane (Abbott Animal Health; 3.5% for induction and 1.8% for maintenance) in a 2 : 1 oxygen and N 2 O mixture and placed in a stereotactic holder. Body temperature was maintained at 37°C and respiration was monitored. Mice were excluded from MRI analyses if their scans showed motion and/or echo planar imaging artifacts. Table S1 contains a list of parameters used in each MRI scan.
Cerebral blood flow (CBF)
To assess CBF, MR perfusion data were acquired under resting conditions using a flow-sensitive alternating inversion recovery technique as previously described Wiesmann et al. 2017) . In short, three regions of interest [ROI; cerebral cortex, hippocampus, and thalamus according to the atlas of Paxinos and Franklin (Paxinos and Franklin 2008) ] were analyzed by two researchers that were blinded to the treatment conditions. CBF was then analyzed for each ROI in both the unaffected (contralateral/left) and affected (ipsilateral/right) hemisphere separately for each dietary group. The loss of CBF in the affected ROI was calculated as the difference in CBF between right and left hemispheric ROI relative to left hemispheric ROI. One mouse of the Control group and also one mouse of the Fortasyn group were excluded from analysis.
Diffusion tensor imaging (DTI)
To assess the integrity of white matter (WM) and gray matter (GM), DTI was performed as previously described Wiesmann et al. 2017) . Mean water diffusivity (MD) and fractional anisotropy (FA) were derived from the tensor estimation following a protocol as described elsewhere . MD is considered an inverse measure of membrane density and is sensitive to changes in GM, while FA is an estimate of myelination and fiber density in WM (Le Bihan et al. 2001; Feldman et al. 2010; Alexander et al. 2011) .
MD and FA values were measured in several WM and GM areas that were manually selected based on an anatomical atlas (Paxinos and Franklin 2008) . No mice were excluded from analysis.
Resting state functional MRI (rsfMRI)
To assess patterns of functional connectivity, resting state functional MRI (rsfMRI) was determined as previously described (Wiesmann et al. 2017) , see the Supporting Information for a detailed description. Based on a previous functional connectivity study in mice (Jonckers et al. 2011 ) seven brain areas (bilateral) were selected for analysis. These areas were: the dorsal hippocampus, the ventral hippocampus, the auditory cortex, the motor cortex, the somatosensory cortex, and the visual cortex. Three mice of the Control group and also three mice of the Fortasyn group were excluded from analysis.
Immunohistochemistry
Immediately following the MRI measurements performed 35 days after the stroke, the mice were killed by transcardial perfusion using 4% paraformaldehyde solution as previously described (Wiesmann et al. 2017) . The brains were collected and separated into two parts. The frontal part of the brain (Bregma: À0.10 to 0.98) was post-fixed in 4% paraformaldehyde, embedded in paraffin and sliced into 5 lm sections. To measure pre-synaptic density, a staining for synaptophysin (SYN) was performed using monoclonal rabbit antisynaptophysin clone EP1098Y (1 : 250; Abcam Inc., Cambridge, UK). The secondary antibody used was donkey anti-rabbit biotin (1 : 200; Jackson ImmunoResearch, West Grove, PA, USA). Quantification of selected stained sections (Bregma: 0.02-0.62) was performed as previously described (Wiesmann et al. 2017) .
After a 24-h incubation in a 30% sucrose solution, the other part of the brain (Bregma: À0.7 to À4.36) was cut in 30 lm frontal sections using a sliding microtome (Microm HC 440, Walldorf, Germany) equipped with an object table for freeze-sectioning at À60°C. These free-floating sections were used to assess (i) vascular integrity, measured with an antibody against glucose transporter-1 (GLUT-1), (ii) neuroinflammation measured with an antibody against ionized calcium-binding adapter molecule 1 (IBA-1) and (iii) immature neurons (i.e., neurogenesis) measured with an antibody against doublecortin (DCX). For GLUT-1, a polyclonal rabbit anti-GLUT-1 primary antibody (1 : 80.000, Chemicon AB 1340, Chemicon International, Inc., Temecula, CA, USA) and a donkey anti-rabbit biotin secondary antibody (1 : 1500 Jackson ImmunoResearch) was used. The primary antibodies used for IBA-1 and DCX were: polyclonal goat anti-IBA-1 (1 : 3000; Abcam) and polyclonal goat anti-DCX (1 : 8000; Santa Cruz Biotechnology Inc., Santa Cruz, CA, USA). For both these proteins, donkey anti-goat biotin (1 : 1500; Jackson ImmunoResearch) was used as a secondary antibody. Quantification of selected stained sections (Bregma: À1.46 to À2.30) was performed as previously described (Wiesmann et al. 2017) . In short, the percentage of stained area (relative to unstained tissue) was determined using ImageJ software (National Institute of Health, Bethesda, MD, USA). Additionally, the number of DCX+ and IBA1+ cells and the number of GLUT-1 + blood vessels was manually counted in selected brain areas. All mice were included for all IHC procedures.
Statistical analysis
For the statistical analysis of outliers and data, IBM SPSS 22 software (IBM Corporation, New York, NY, USA) was used. A multivariate ANOVA, univariate ANOVA or repeated measures ANOVA with Bonferroni corrections was conducted with betweengroup-factor diet and, if necessary, time and left-to-right-hemisphere-differences to analyze possible differences. Statistical significance was set at p < 0.05, with p < 0.08 considered a trend. Degrees of freedoms, F-values, and p-values are given for each statistical analysis. All data are expressed as mean AE SEM.
Results
Body weight, diet intake, and estrous cycle To assess the well-being of the mice and monitor intake of the diets, body weight and diet intake were measured every week. Before stroke and subsequent diet switch, the average body weight of the mice that were randomly allocated to the Control diet group (21.3 AE 0.30 gr) was lower (F(1, 21 = 4.7, p = 0.042) than the body weight of the mice that were going to receive the Fortasyn diet (22.2 AE 0.28 gr; data not shown). To correct for this baseline difference, body weight differences after stroke and diet switch were all determined relative to prestroke weight (Fig. S1a) . Compared to baseline, the body weight of the mice decreased in the first week after stroke induction and diet switch (À16.1 AE 1.6%; F(1, 21) = 108.4, p < 0.001). In the next 2 weeks, body weight of all mice increased with 9.22 AE 0.87% (F(1, 21) = 113.5, p < 0.001) relative to their weight in the first week after stroke and diet switch. In weeks 3-5 after the stroke, the body weight of all mice stabilized. Five weeks after the stroke and diet switch, body weight was 5.89 AE 1.3% lower than pre-stroke body weight (F(1, 21) = 19.9, p < 0.001). There was no diet effect on body weight.
Food intake was monitored after stroke and diet switch (Fig. S1b) . In the first week after stroke and diet switch, mice on Fortasyn diet had a higher average daily food intake than the mice on control diet (3.14 AE 0.09 vs. 2.52 AE 0.08 gr/ day; F(1, 21) = 5.3, p = 0.032). Average daily food intake of both diet groups increased in the following week (F(1, 21) = 16.4, p = 0.001), followed by a decrease in week 3 (F (1, 21) = 21.4, p < 0.001). In weeks 3-5 after the stroke, average daily food intake of all mice stabilized. There were no differences in average daily food intake between Control diet and Fortasyn diet after the first week.
Thirty-five days after the stroke, the stage of the estrous cycle of each individual mouse was evaluated by visual observation based on (Byers et al. 2012) . A digital image of each mouse was taken. Each experimental mouse was in the diestrus stage of the estrous cycle.
Behavior, cognition, and motor tasks
Open field To measure activity, anxiety, and explorative behavior, a 10-min open field test was performed before stroke (prestroke baseline) and 3 and 21 days after the stroke and subsequent diet switch (Fig. 2) . Compared to baseline, mice on both diets moved a shorter distance 3 days after stroke (Fig. 2a: F(1, 20) =46.8, p < 0.001) and had a lower velocity (F(1, 20) =46.7, p < 0.001; data not shown). Both parameters remained decreased 21 days after the stroke (distance: F(1, 20) = 0.920, p = 0.349; velocity: F(1, 20) = 0.924, p = 0.348). There was no diet effect on these parameters at 3 or 21 days after the stroke.
The frequency of performing different types of (exploratory) behavior was manually scored (Fig. 2b) . Three days after the stroke and subsequent diet switch, the frequencies of walking (F(1, 20) Three days after stroke and diet switch, mice on Fortasyn diet reared more frequent than mice on control diet (F(1, 20) = 7.1, p = 0.015). There were no other effects of diet within these parameters.
To assess anxiety and exploration, the position of the mice in the open field (center, corners, periphery) was determined Fig. 2 Activity, anxiety, and (explorative) behavior was measured in the open field pre-stroke (pre) and 3 days (3d) and 21 days (21d) after stroke induction and diet switch. (a) Compared to pre-stroke, 3 days after the stroke all mice moved less distance. The distance moved remained decreased 21 days after the stroke. (b) Compared to prestroke, the frequency of walking and rearing decreased 3 days after the stroke, while the frequency of sitting increased. Rearing frequency decreased further 21 days after stroke compared to 3 days after stroke. Mice fed the Fortasyn diet reared more frequently 3 days after the stroke induction and diet switch. (c) Compared to pre-stroke, the frequency of entering the center, corners and periphery decreased 3 days after the stroke. (d) The time spent in the center and periphery decreased compared to pre-stroke, while the time spent in the corners increased. The time spent in the periphery had decreased further 21 days after stroke induction and the time spent in the corners increased further. Values represent mean AE SEM. Control: n = 12, Fortasyn: n = 10. *p < 0.05, **p < 0.01, ***p < 0.001.
( Fig. 2c and d) . Three days after the stroke, all mice visited the corners (F(1, 20) = 13.0, p = 0.002), periphery (F(1, 20) = 26.0, p < 0.001), and center (F(1, 20) = 19.1, p < 0.001) of the open field less frequently than before the stroke (Fig. 2c) . Time spent in the center and periphery decreased (Fig. 2d: F(1, 20) = 7.33, p = 0.014 and F(1, 20) = 12.9, p = 0.002, respectively) for all mice compared to pre-stroke (while time spent in the corners increased (F(1, 20) = 20.7, p < 0.001). Three weeks (21 days) after stroke, the number of visits to the center decreased further (Fig. 2c: F(1, 20) = 6.4, p = 0.020). There was no change in the number of visits to the corners (F(1, 20) = 0.10, p = 0.920) or periphery (F(1, 20) = 1.22, p = 0.282) compared to 3 days after the stroke. The time spent in the corners did increase further for all mice (Fig. 2d:  F(1, 20) = 11.7, p = 0.003) compared to 3 days after stroke, while time spent in the periphery decreased further (F(1, 20) = 8.49, p = 0.009). Time spent in the center slightly tended to decrease (F(1, 20) = 3.56, p = 0.074). There was no effect of diet on the positions within the open field at either time point after stroke. Before stroke induction, the mice that would receive Fortasyn spent less time in the corners than the mice that would receive Control diet (Fig. 2d: F(1, 20) = 4.57, p = 0.045).
Grip strength test
The grip strength of the mice was tested before stroke induction (pre-stroke baseline) and 14 and 27 days after stroke females (n = 11) tended to have a higher prepulse inhibition (PPI) (%) than Control stroke females (n = 10) when a prepulse of 4 dB was given (PP4). There was no effect of diet with any of the other prepulses. (d) Fortasyn stroke females (n = 11) habituated to the 120 dB startle pulses as demonstrated by a reduction in startle response from the beginning to the end of the PPI test. Values represent mean AE SEM. Abbreviations: g-f, gram-force; PP, prepulse (of either 2, 4, 8, or 16 dB above background noise); PPI, prepulse inhibition; a.u., arbitrary units. #p < 0.08, *p < 0.05, **p < 0.01. stroke and subsequent diet switch (Fig. 3a) . Mice had to repeatedly pull either a trapeze with their forepaws or a grid with all four paws and the maximum grip strength (in gramforce) was recorded. Two weeks after the stroke, maximum limb strength on the grid of all mice was lower than at baseline (F(1, 20) =7.71, p = 0.012), while maximum strength on the trapeze was unaltered (F(1, 20) = 0.977, p = 0.335). There was no change in strength when comparing 14 days and 27 days after the stroke (trapeze: F(1, 20) = 0.04, p = 0.851; grid: F(1, 20) = 0.71, p = 0.411) nor was there any diet effect.
Pole test
Motor coordination was determined 15 days after the stroke and subsequent diet switch (Fig. 3b) . Mice were repeatedly placed on a pole facing upward and the time needed to turn around its body axis and the speed of the mouse while descending the pole were measured. Diet had no effect on either parameter.
Prepulse inhibition (PPI)
To assess sensorimotor integration, a PPI test with four different, randomly administered prepulses (PP2, PP4, PP8, and PP16) was performed 16 days after stroke and subsequent diet switch ( Fig. 3c and d) . In this test, mice that received the Fortasyn diet tended to have a higher PPI than Control animals when a prepulse that was 4 dB louder than background noise was given (Fig. 3c : PP4: 40.7 AE 5.0% and 23.2 AE 7.2%, respectively; F(1, 19) = 4.1, p = 0.056). There was no other diet effect on PPI.
Fortasyn mice, but not Control mice (F(1, 9) = 0.55, p = 0.477), habituated to the 120 dB pulses, as demonstrated by a reduction in the startle response triggered by these pulses from the beginning (12.5 AE 1.4) to the end (9.9 AE 0.9) of the test (Fig. 3d: F(1, 10) = 5.5, p = 0.04).
Novel object recognition test
To assess cognitive function, 22 and 23 days after stroke induction and diet switch, a novel object recognition test was performed with a 30-or 60-min intertrial interval, respectively. There was no effect of diet on recognition memory (data not shown).
MRI measurements
Cerebral blood flow (CBF)
To assess stroke and diet effects on brain perfusion, CBF was measured in three brain regions (in both left and right hemisphere) 7 and 35 days after the stroke and subsequent diet switch (Fig. 4) . Seven days after the stroke, CBF in the right cortex (Control: F(1, 20) = 4.4, p = 0.050; Fortasyn: F (1, 18) = 15.6, p = 0.001), right hippocampus (Control: F(1, 20) = 43.2, p < 0.001; Fortasyn: F(1, 18) = 83.3, p < 0.001), and right thalamus (Fortasyn: F(1, 18) = 11.5, p = 0.003) was lower than in the corresponding left ROI (Fig. 4a) . There was no difference between the diets at this time point.
Thirty-five days post-stroke (Fig. 4a) , mice on both diets demonstrated lower CBF in the right hippocampus (Control: F(1, 20) = 30.4, p < 0.001); Fortasyn: F(1, 18) = 34.5, p < 0.001) compared to the left hippocampus. Additionally, mice on Fortasyn had a lower CBF in the right cortex (F(1, 18) = 4.9, p = 0.041) and in the right thalamus (F(1, 18) = 8.4, p = 0.010) compared to the corresponding left ROI. Fortasyn mice tended to have a higher CBF (243.8 AE 11.5) than Control mice (211.2 AE 11.0) in the left thalamus (F(1, 19) = 4.2, p = 0.05).
Over time (35 days vs. 7 days post-stroke), mice on Fortasyn diet showed an increase in CBF in the right hippocampus (F(1, 9) = 9.9, p = 0.012) and in the right cortex (F(1, 9) = 4.2, p = 0.072) (Fig. 4a) . These effects were not seen in mice on Control diet. In both diet groups, the CBF difference between the right and left hippocampus, that is, loss of CBF, decreased ( Fig. 4c : Control, F(1, 10) = 8.7, p = 0.015; Fortasyn, F(1, 9)=37.0, p < 0.001) over time. A similar decrease over time was also revealed in the thalamus of Fortasyn mice (F(1, 9) = 17.2, p = 0.002), but not significant in the cortex of Control mice (F(1, 10) = 3.8, p = 0.080).
Diffusion tensor imaging (DTI)
To assess brain integrity, quantitative assessment of diffusion tensor-derived indices (fractional anisotropy, FA, Fig. 5a ; and mean diffusivity, MD, Fig. 5b ) was performed for nine white and gray matter regions 7 and 35 days after stroke and diet switch.
Fractional anisotropy (FA)
Seven days after stroke (Fig. 5a ), mice had a lower FA in the right caudate putamen and globus pallidus region (Cpu+GP; Control:
F ( Thirty-five days after the stroke (Fig. 5a ), mice had a lower FA in the right Cpu+GP We also investigated FA differences over time from 7 days to 35 days post-stroke (Fig. 5a) . Control mice showed a decrease in FA over time in both the left (F(1, 11) = 39.6, p < .001) and right (F(1, 11) = 57.1, p < 0.001) auditory cortex (AUC), left (F(1, 11) = 34.2, p < 0.001) and right HC (F(1, 11) = 4.9, p = 0.05), left MC (F(1, 11) = 4.1, p = 0.068), the left (F(1, 11) = 16.9, p = 0.002) and right somatosensory cortex (SSC; F(1, 11) = 11.5, p = 0.006) and in the left (F(1, 11) = 10.0, p = 0.009) and right VC (F(1, 11) = 12.5, p = 0.005). Furthermore, Control mice demonstrated an increase in FA over time on both the left (F(1, 11) = 71.0, p < 0.001) and right optic tract (OT; F(1, 11) = 40.8, p < 0.001). Except for a tendency to an increase in FA in the left OT (F(1, 10) = 4.0, p = 0.075), Fortasyn mice showed no FA changes over time.
Mean diffusivity (MD)
Seven days after stroke (Fig. 5b ), mice had a higher MD in the right OT (Control: F(1, 22) = 6.6, p = 0.018; Fortasyn: F(1, 20) = 9.1, p = 0.007) compared to the left OT. Furthermore, in Control mice, but not Fortasyn mice, MD in the right HC was higher than in the left HC (F(1, 22) = 5.0, p = 0.036). There were no other left-right differences at this time point nor were there diet effects present.
Thirty-five days after the stroke (Fig. 5b) , MD of mice on Control diet was higher in the right AUC (F(1, 22) = 10.1, We also investigated MD differences over time from 7 to 35 days post-stroke (Fig. 5b) . Control mice showed an increase in MD over time in the fornix (F(1, 11) = 8.5, p = 0.014), left HC (F(1, 11) = 8.7, p = 0.013), and both left (F(1, 11) = 24.8, p < 0.001) and right OT (F(1, 11) = 9.6, p = 0.010). Fortasyn mice only demonstrated an increase over time in the MD of the left OT (F(1, 10) = 14.4, p = 0.003).
Resting state fMRI (rsfMRI)
To compare functional connectivity (FC) patterns, 7 and 35 days after stroke and diet switch total and partial rsfMRI correlations were determined for six brain regions. With total correlations, no significant diet nor time effects could be detected (data not shown). Partial correlation analysis (Fig. 5c) , accentuating the direct connectivity between two ROI while regressing the temporal BOLD signal from all other ROI, revealed significant time effects in mice on both diets (Fig. 5e) (Fig. 5d) .
Immunohistochemistry
After killing the mice, immunohistochemical stainings were performed on selected brain areas to assess neurogenesis (DCX), vascular density (GLUT-1), neuroinflammation (IBA-1), and pre-synaptic density (SYN). No left-right differences were detected in any of the stainings (Fig. 6) .
Compared to Control mice, Fortasyn mice had a larger DCX+ area in the subventricular zone (Fig. 6a:  F(1, 42) = 4.1, p = 0.050), while the number of DCX+ neurons in the hippocampus did not differ (data not shown). Fortasyn-fed mice had both a larger relative IBA-1+ area (Fig. 6e: F(1, 42) = 6.1, p = 0.018) and more IBA-1+ cells than Control fed mice (Fig. 6d: F(1, 42) = 4.2, p = 0.046) in the cortex. In the hippocampus and thalamus, no diet effects on these parameters were detected (data not shown). In the hippocampus, Fortasyn mice furthermore exhibited a lowered vascular density (i.e., number of Glut-1+ vessels) compared to Control fed mice (Fig. 6h: F(1, 42) = 6.5, p = 0.014). No diet effects were found for the number of Glut-1+ vessels in the cortex and thalamus or the relative Glut-1+ area in any of the assessed ROI (data not shown). Finally, relative SYN+ area did not differ between the diet groups (data not shown).
Discussion
In search for much needed novel therapies for stroke, interventions with dietary components appear promising (Aquilani et al. 2011; Belayev et al. 2011; Schwarzkopf et al. 2015) . Indeed, previously we determined that a multinutrient intervention (Fortasyn) first developed for use in early AD could improve brain perfusion, brain connectivity, and motor function after the induction of a transient experimental focal ischemic stroke in male C57Bl/6 mice (Wiesmann et al. 2017) . As it may be expected that female mice respond differently to treatment than males (Soldin and Mattison 2009) , in this study, we further examined the therapeutic potential of this multinutrient intervention in female mice. As far as we know, we are the first to treat stroke females with Fortasyn. In fact, only a small percentage of preclinical studies investigating mechanisms or interventions of stroke have been performed using female rodents (Beery and Zucker 2011) and, with few exceptions [e.g., (Janickova et al. 2015; Broersen et al. 2013) ], most of the preclinical studies tested the efficacy of Fortasyn in males (de Wilde et al. 2011; Jansen et al. 2013 Jansen et al. , 2014 Wiesmann et al. 2013 Wiesmann et al. , 2016 Wiesmann et al. , 2017 Zerbi et al. 2014; Cansev et al. 2015) . In our stroke females, the induction of a focal ischemic lesion by tMCAo impaired the activity and motor skills of the mice and affected the perfusion, integrity, and connectivity of the brain. The effects of Fortasyn on stroke-induced impairments in the females were diverse. Fortasyn improved brain integrity and neurogenesis and, to some extent, CBF and brain connectivity, but did not affect deficits in activity or motor skills. Increased inflammation and decreased vascular density in the Fortasyn-treated stroke females need further study for a proper interpretation. Sensorimotor integration, as assessed in the PPI test, however, did seem to benefit from Fortasyn in these females, while no effects were previously observed in males (Wiesmann et al. 2017) .
Cerebral hemodynamics
In the male stroke mice, Fortasyn improved cerebral perfusion (Wiesmann et al. 2017) , which is in line with the beneficial effects of Fortasyn on CBF seen in our previous studies using mouse models for AD Wiesmann et al. 2016) . In line with the previous studies, Fortasyn did also increase CBF in the stroke females with time in individual brain areas such as the right cortex and right hippocampus. However, different from the Fortasyn stroke males (Wiesmann et al. 2017) left-right differences in CBF in the female Fortasyn mice did not totally recover with time. Therefore, it seems as though the cerebral blood flow in stroked females did not benefit from Fortasyn to the same extent as it did in the male stroke mice and it remains to be investigated why the stroke females on Fortasyn did not show at least a similar recovery. Future studies should therefore investigate also the impact of such a multinutrient intervention on possible mechanisms (e.g., smooth muscle cell behavior) being involved in the cerebral vasoreactivity.
Brain integrity, sensorimotor integration, and functional connectivity Stroke effects on WM and GM integrity are clearly present in the females. Indeed, these stroke effects seem more extensive than the stroke effects on brain integrity seen in the males (Wiesmann et al. 2017) , that is, a greater number of brain areas demonstrate ipsilateral WM and GM integrity impairments in the females. This finding seems in contrast to the well-known fact that specifically in women estrogens should be able to reduce stroke-induced brain damage (Liu et al. 2010) . A study simultaneously examining stroke effects in both male and female mice may resolve this discrepancy.
Fortasyn seems to inhibit the progressive impairment of WM and GM microstructure that was demonstrated in the female stroke mice fed the Control diet. Furthermore, in several brain areas, WM and GM integrity of the Fortasyn mice was higher than in the Control mice. These beneficial effects of Fortasyn are in line with previous studies testing the effect of (components of) this multinutrient intervention on brain integrity (Jiang et al. 2016; Wiesmann et al. 2016) and they are furthermore supportive of the membrane synthesizing potential of this particular multinutrient intervention (van Wijk et al. 2014) . Up to now, mechanisms are still unknown how tissue integrity could be influenced by dietary components like omega-3 fatty acids. Notably, investigating T2-values to detect changes in brain membrane composition, Hirashima et al. (2004) demonstrated in women with bipolar disorder that omega-3 fatty acid supplementation for 4 weeks lowered T2 values indicating a treatment-induced increase in membrane fluidity. This result could help us to understand the beneficial also treatment-induced effects on WM and GM microstructure being found in our study. As stroke-induced WM impairments can cause sensorimotor impairments (Wang et al. 2016) , the improved performance in the PPI test by Fortasyn-treated mice may be linked to the rescue of WM integrity by this diet. Indeed, in mice treated with n-3 polyunsaturated fatty acids, improvements in WM integrity were positively correlated with sensorimotor performance in the cylinder test (Jiang et al. 2016) . The beneficial effect of Fortasyn on sensorimotor integration in this study may be indicative of the efficacy of multinutrient interventions in psychiatric disorders with extensive sensorimotor impairments, such as schizophrenia and Gilles de la Tourette's syndrome (Geyer 2006; Kohl et al. 2013) .
Our MRI data revealed that the enhancement of brain integrity by Fortasyn was accompanied by a Fortasyn-specific improvement of functional connectivity in stroke females; comparably to stroke males (Wiesmann et al. 2017) , Fortasyn increased FC between the right AUC and the left MC. However, while the stroke males showed several beneficial effects of Fortasyn on FC, in the females, this effect was limited to this one improved connection. An explanation for this modest effect of Fortasyn in the females may be that the duration of treatment (i.e., 35 days) was insufficient to elicit a substantial beneficial effect of Fortasyn on stroke-induced impairments of functional connectivity present in our stroke females. Indeed, previously when Fortasyn improved functional connectivity, treatment periods could last up to 16 months (Wiesmann et al. 2016) . The relatively short duration of our treatment may also explain the lack of a (beneficial) effect of Fortasyn on the synaptic marker SYN in both female and male mice (Wiesmann et al. 2017) . In ApoE4 mice, levels of a post-synaptic marker, PSD-95, were unaffected with 10 months of treatment with Fortasyn diet, but finally increased after 16 months of treatment (Wiesmann et al. 2016) .
Neurogenesis and inflammation
Stroke can trigger neurogenesis both in rodent and human brain (Lindvall and Kokaia 2015) , presumably in an effort to repair the ischemic damage, but this neurogenesis is insufficient to induce lasting, functional recovery. While we did not investigate effect of tMCAo on neurogenesis, in this study, we did find that Fortasyn can enhance neurogenesis in both the ipsi-and contralateral subventricular zones. It seems that Fortasyn is capable of enhancing the production of novel cells after stroke, which is in line with the effect of Fortasyn on neurogenesis seen in the stroke males (Wiesmann et al. 2017) and in male APP/PS1 mice . It remains to be investigated whether these novel cells can develop into mature and functional cells capable of repairing stroke damage.
Functional integration of novel cells into damaged areas in part relies upon the presence of a beneficial inflammatory environment. An ischemic event in the brain triggers an immediate inflammatory response, with recruitment and activation of microglia particularly in the affected ischemic brain area (Taylor and Sansing 2013) . In this study, there was no difference between the affected hemisphere and the unaffected hemisphere regarding Iba-1 expressing inflammatory cells, perhaps because the initial inflammatory response occurring immediately after stroke induction had already vanished 35 days after the stroke. However, compared to the mice fed the Control diet, the Fortasyn mice demonstrated more IBA-1+ cells in the cortex, suggesting that Fortasyn can modulate inflammation. As IBA-1 expressing microglia are capable of being both harmful and protective (Taylor and Sansing 2013) , discovering the exact nature of a Fortasyninduced inflammatory response in both females and males is necessary to establish if Fortasyn has a beneficial or detrimental effect on inflammation.
Motor function, behavior, and cognition tMCAo is known to result in impairments of motor skills and activity (Balkaya et al. 2013) , and indeed the stroke females demonstrated functional impairments. Stroke males on the Fortasyn diet showed improvements in motor strength, motor coordination, and activity compared to Control mice (Wiesmann et al. 2017), but none of these effects could be replicated in the stroke females. Three days after stroke induction, Fortasyn-fed females did demonstrate increased rearing frequency compared to Control females. Finally, the ORT revealed that Fortasyn did not affect cognition in the stroke females, probably because the ORT was measured from 22 to 24 days post-stroke. Another study demonstrated a significantly reduced preference at 7 and 14 days following stroke, but also normal values between 21 and 28 days post-stroke suggesting recovery of cognition after 3 to 4 weeks (Wang et al. 2012) . Therefore, in future research, ORT or other cognition tests should be performed earlier after the induction of the experimental stroke to detect subtle deficits and dietary effects. Nevertheless, MCAo leads to a range of cognitive changes, relying upon gender, strain, and the occlusion time (Jiwa et al. 2010) . Moreover, in some studies impaired learning with the Morris water maze (MWM) was found (Gibson and Murphy 2004) , while other studies could not replicate this result (Bou€ et et al. 2007 ) indicating possible differences in cerebral vasculature between murine strains. Thereby cognitive decline in patients is influenced by co-morbidities and preexisting conditions that affect the entire brain (and pre-dispose stroke) and these conditions are hard to model in the otherwise healthy rodent with only a restricted unilateral injury.
Conclusion
As previously demonstrated, treatment with the Fortasyn multinutrient intervention has multiple beneficial effects on impairments seen in AD (van Wijk et al. 2014 ) and ischemic stroke (Wiesmann et al. 2017 ). In the current preclinical stroke study, as far as we know one of the first to use females, the beneficial effects of the Fortasyn diet were less pronounced compared to those found in male mice (Wiesmann et al. 2017) , perhaps because the stroke seemed to impact the females more severely than the males. This suggests that indeed, as previously observed (Soldin and Mattison 2009) , the outcome of treatment in males and females can differ and emphasizes the necessity to include both sexes in preclinical studies, preferably simultaneously. Rodents like mice and especially the female mice may be affected by the dissimilar amount of phytoestrogens in the two diets. This difference may also explain that in this recent study less beneficial effects of the Fortasyn diet were found in female stroke mice than in male stroke mice compared to the Control diet. However, very small amounts of phytoestrogens are present in soy oil and even smaller amounts will be present in the control diet containing 3% soy oil which will in all probability not provide ample amounts to evoke a physiological response in mice. Nevertheless, in future research this should be taken into consideration when composing the diets. In our opinion, the fact that the effects of Fortasyn in this study were diverse does not negate the efficacy of multinutrient intervention treatments in the recovery of female stroke patients. As discussed, stroke females may benefit from extended treatment durations. Furthermore, testing multinutrient interventions in female mice modeling the changes occurring with menopause, for example, an ovariectomized female mouse (Diaz Brinton 2012), may be more appropriate to assess the effects of interventions in stroke females. In our opinion, these future studies, together with this study, will help create effective dietary treatment regimens for CVD such as stroke in both females and males. Nevertheless, a longer multinutrient intervention period would possibly have a much stronger effect on cardio-and cerebrovascular health, and potentially have some benefit to prevent dementia via increasing cognitive reserve. Future studies should take this into account and study the effect of longer dietary treatments. Multinutrient interventions seem to be a beneficial add-on to the already existing ways of therapy (thrombolysis and/or thrombectomy) to enhance recovery of (female) stroke patients. Therefore, future studies are needed to investigate the efficacy of the treatment combination of the traditional stroke therapies with such a multinutrient intervention. All experiments were conducted in compliance with the ARRIVE guidelines. The authors have no conflict of interest to declare.
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